New Science,
Better Experiences.
ORGANOIDSCIENCES, Redefining treatment through life science innovation as a leading bio-innovation company
Organoid Based High-End Technology
Organoid-based innovation for precise and proactive care
ATORM
Organoid-Based Regenerative Therapeutics Platform
- Provides fundamental treatments for various diseases that are difficult to address with conventional pharmaceuticals
- Unlike existing regenerative therapies, offers therapeutics based on direct regenerative mechanisms
ODISEI
Organoid-Based Novel Material Evaluation Solution
- Addresses the challenges of skyrocketing drug development costs and the lack of preclinical evaluation models for new modality drugs
- Provides animal-free testing methods in response to animal welfare concerns and regulatory policies by agencies like the FDA and EMA to minimize animal testing
PODOTX
Polaris Platform for Evaluating Immunotherapy Sensitivity
- Reflects individual patient characteristics and provides intuitive response prediction
- High sensitivity, specificity, and accuracy
Expansion
Organoid-Based Expansion Platform
- Research products for organoid cultivation
- Contract manufacturing for cell therapy products
ORGAN-OID
Three-dimensional cultured organ-like structures that replicate the architecture and function of real organs
1
Contains organ-specific cells
2
Capable of spatial organization
3
Replicates organ-specific functions
Enterocyte
Enteroendocrine Cell
Goblet Cell
Transit Amplifying Cell
Stem Cell
Overcoming the limitations of conventional therapies
Organoid-based regenerative
therapeutics platform
Overcoming the limitations of
animal testing
Organoid-based drug efficacy and
toxicity evaluation platform
Paradigm Shift in Drug Development and Therapeutics Market
01
Regenerative
therapeutics
02
Precision medicine & Companion diagnostics
03
Nutraceuticals
04
RUO
Organoids can be applied
in various fields
05
CDMO
06
Companion
animal care
07
New drug
development
다양한 분야에 통합될 수 있습니다
1
재생치료제
4
RUO
06
반려동물
2
정밀의료&동반진단
3
건강기능식품
05
CDMO
07
신약개발
The Organoid Era Is Already Upon Us
Developing regenerative therapies with adult stem cells to fundamentally improve patients’ lives
Patient-derived organoids precisely model human biology, enabling personalized precision medicine
Advancing an ethical paradigm of treatment by reducing unnecessary experimentation through scientific progress
Commercialization of Organoid-Based Regenerative Therapeutics through the Advanced Regenerative Medicine Act and National Strategic Technologies
- Clinical trials under the Korean Advanced Regenerative Medicine Act are expected to conclude, with prescriptions beginning at medical institutions starting in 2027.
- Full-scale domestic sales will follow, and by 2028, global commercialization (LO) will be pursued, positioning the company as a global leader in the organoid-based therapeutic market.
Regulatory Framework for Organoid Evaluation Methods through the U.S. FDA Modernization Act and Korea’s Ministry of Food and Drug Safety (MFDS)
- ODISEI has been commercially available since 2021 and has demonstrated steady revenue growth.
- After reaching 4 billion KRW in revenue in 2025, it is expected to continue growing, with a target of approximately 30 billion KRW by 2028.
The partner of choice for industry-leading companies
Organoid Sciences의 최신 소식과 이야기를 만나보세요
오가노이드 구매 문의
2025년 4월월 15일 #Conquer #Cancer #AI
오가노이드 기반 조직 별 약물 반응성 평가 문의
2025년 4월월 15일 #AI #암정복 #루닛
오가노이드 분양 문의
2025년 4월월 15일 #인공지능 #AI #컨퍼런스
전체 글 보기
Toward a Sustainable Future with ORGANOIDSCIENCES
Join ORGANOIDSCIENCES in leading groundbreaking organoid research and the advancement of next-generation cell therapies.
Be part of the journey of biomedical innovation that is shaping the future of healthcare.
Be part of the journey of biomedical innovation that is shaping the future of healthcare.
Technical Inquiry
bd@organoidrx.com
PR/Marketing inquiry
pr@organoidrx.com
Recruitment inquiry
hr.admin@organoidrx.com
General Inquiry
info@organoidrx.com